Company / Return on Assets (ROA)
KIORA PHARMACEUTICALS INC Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
14.8%
FY2025
5-year range
-106.9% / 14.8%
FY2021-FY2025
Trend
+143.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -106.9% in FY2019 to 14.8% in FY2025.
Based on SEC 10-K filings.
14.8% in FY2025 with a 5-year CAGR of +61.6%.
Improved from -53.4% to 14.8% over the past 4 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +61.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 143.2% year-over-year.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.8% | +143.2% |
| FY2024 | -34.3% | +35.8% |
| FY2021 | -53.4% | -14.0% |
| FY2020 | -46.8% | +56.2% |
| FY2019 | -106.9% | -15.5% |
| FY2018 | -92.6% | +0.8% |
| FY2017 | -93.3% | -8.2% |
| FY2016 | -86.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026